Children in foster care — nearly all of whom are covered by Medicaid — are more likely than other children to receive psychotropic medications. Significant variations in the use of psychotropic medications also exist across Medicaid programs, suggesting that there are opportunities to implement better systems of oversight and monitoring to reduce the inappropriate use of these drugs.

This resource center houses publications, tools, and webinars to help states that are seeking to improve the oversight and monitoring of psychotropic medication use for children in foster care. These resources are a product of CHCS’ Psychotropic Medication Quality Improvement Collaborative, made possible by the Annie E. Casey Foundation, a three-year collaborative that supported six states in assessing and improving the strength of their oversight and monitoring systems.

Common Measures and OutliersAssessment PracticesAgency Consent for Psychotropic Medication UsePsychiatric ConsultationStakeholder EngagementState and Federal Guidance